2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Urogenital Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Ovarian Cysts
1
Neoplasms
1
Gonadal Disorders
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Endocrine System Diseases
1
Endocrine Gland Neoplasms
1
Disease
1
Cysts
1
Adnexal Diseases
1
Interventions
Gemcitabine
5
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
selpercatinib
2
niraparib
2
napabucasin
2
entinostat
2
Ocoxin
2
Irinotecan
2
Bevacizumab
2
temsirolimus
1
tariquidar
1
repotrectinib
1
pralsetinib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
ganitumab
1
copper dotatate CU-64
1
Valproic Acid
1
Trabectedin
1
Therapeutic Irrigation
1
Taxes
1
Sunitinib
1
Staining and Labeling
1
Sirolimus
1
Psilocybin
1
Phlebotomy
1
Paclitaxel
1
Oxaliplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Endocrine Gland Neoplasms
×
Diffusion
×
Clear all
NCT02836275
2020-04-14
IOTA-MRI
KU Leuven
Phase NA
Unknown
250 enrolled